Q Fever News and Research

RSS

Paclitaxel Poliglumex/Capecitabine regimen well tolerated and active in metastatic breast cancer

At the 2008 Annual Meeting of the American Society of Clinical Oncology (ASCO), data were presented from a phase II investigator-sponsored trial paclitaxel poliglumex (Opaxio, CT-2103) in combination with capecitabine in first-line treatment of patients with metastatic breast cancer (MBC).

3 Jun 2008

Probiotics provide hay fever hope

With the peak grass pollen season approaching, scientists can reveal that a daily dose of probiotic can change the immune status of people with hay fever.

2 Jun 2008

New research into superbug Clostridium difficile

New research into the toxins, virulence, spread and prevention of the superbug Clostridium difficile is reported in the June special issue of the Journal of Medical Microbiology. These findings will play a crucial role in providing us with ammunition in the fight against a sometimes deadly pathogen.

1 Jun 2008

US$28 million needed for Myanmar says WHO

WHO and its Health Cluster partners in Myanmar have launched a six-month and US$ 28 million action plan to provide immediate health care for cyclone survivors and to support longer-term efforts to rebuild the country's ravaged health system.

30 May 2008

New generation of insect repellents in the pipeline

The next generation of insect repellents could be in the pipeline with research from the U.S. suggesting seven possibilities.

27 May 2008

Emergency measures employed to stop measles epidemic

Emergency measures are being adopted in Britain to tackle the escalating numbers of new measles cases.

22 May 2008

Scientists paint-viruses with proteins to track and treat viral disease and evolution

Biologists from Austria and Singapore developed a technique that adds a new twist on the relationship between biology and art. In an article recently published online in The FASEB Journal and scheduled for the August 2008 print issue, these researchers describe how they were able to coat-or paint-viruses with proteins.

20 May 2008

Plant flavonoid luteolin reduces inflammatory response in the brain

Researchers at the University of Illinois report this week that a plant compound found in abundance in celery and green peppers can disrupt a key component of the inflammatory response in the brain. The findings have implications for research on aging and diseases such as Alzheimer's and multiple sclerosis.

20 May 2008

Majority of kidney cancers diagnosed at earliest stage

Patients in the United States today are now much more likely to be diagnosed with smaller tumors, in the earliest, most treatable stage of kidney cancer than a decade ago, leading to a slightly higher survival rate, according to the results of a national study led by a UC San Diego Medical Center researcher.

19 May 2008

New hay fever jab promises year long relief for sufferers

Relief is in sight for millions of hay fever sufferers with the promise of a jab, which lasts for a year, that significantly reduces symptoms.

15 May 2008

Population affected by cyclone in Burma/Myanmar

As many as 3.2 million Burmese are estimated to be affected by the devastation caused by Cyclone Nargis, according to geographic risk models developed by researchers from the Johns Hopkins Bloomberg School of Public Health and Lehman College, CUNY.

14 May 2008

Death toll in China now at 39 as 5 more children die from enterovirus 71

The death toll in China from enterovirus 71 (EV71) has risen to 39 with the deaths of five more children; EV71 belongs to the same family as the polio virus and is a strain of hand, foot and mouth disease (HFMD).

13 May 2008

FDA approves new formulation of genetically engineered version of Factor VIIa plasma protein

The U.S. Food and Drug Administration today approved a new formulation of the genetically engineered version of Factor VIIa, a plasma protein essential for the clotting of blood. The new formulation allows the product to be stored at room temperature (up to 81 degrees Fahrenheit) for up to two years.

9 May 2008

Study affirms effectiveness of medication for juvenile rheumatoid arthritis

Juvenile rheumatoid arthritis (JRA) is a chronic autoimmune disease that strikes children between the ages of newborn to 16 years. All children with JRA have joint pain, stiffness, and swelling and some also have fever and skin rashes.

9 May 2008

China struggling to come to grips with enterovirus 71

As health authorities in China struggle to come to grips with an outbreak of the intestinal virus EV71 or Enterovirus 71, the Ministry of Health is urging local health officials to step up public health education.

8 May 2008

Researchers highlight distinct subtypes of myalgic encephalomyelitis

Researchers have identified distinct subtypes of myalgic encephalomyelitis (ME/CFS - also referred to as chronic fatigue syndrome) and there is renewed hope that treatments are available for this debilitating neurological illness.

7 May 2008

Nurse care for schizophrenia patients

Drug and psychosocial interventions for the symptoms of schizophrenic disorders contribute to a lower incidence and prevalence of schizophrenia. Nurses will be able to offer better care through the use of nursing models and theories in the care of Schizophrenics.

6 May 2008